BeautyHealth Q3 2025 revenue $70.7M down 10% YoY; Adj EBITDA $8.9M beats guidance

SkinHealth Systems Inc.

2025-Q3 EPS reported -$0.11 vs consensus -$0.07 ▼ miss (-59.2%)

Net sales of $70.7M vs $78.8M YoY; net loss improved to $11.0M from $18.3M.
Adjusted EBITDA of $8.9M (12.6% margin) exceeded top end of guidance range.
Delivery systems sold 875 vs 1,118 YoY; consumables net sales $49.8M vs $51.2M.
Active install base grew to 35,409 from 34,162 YoY.
CEO cites disciplined execution; no FY guidance range updated in the release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.